AFJK - NASDAQ
Aimei Health Technology Co., Ltd
$40.87
-5.0%Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
At a Glance
Live Snapshotafjk
Total Liabilities and Equity
Last Annual Value
12.10M
3-Year CAGR
-44%
5-Year CAGR
-30%
10-Year CAGR
-16%
Aimei Health Technology Co., Ltd Competitors Analysis of Total Liabilities and Equity
| Company | Total Liabilities and Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
 Aimei Health Technology Co., Ltd NASDAQ:AFJK | 12.10M | -44.4% | N/A | N/A | |
 Israel Acquisitions Corp NASDAQ:ISRL | 82.63M | -18.8% | 361.8% | -5.2% | |
 Origin Investment Corp I Units NASDAQ:ORIQU | 1.26M | N/A | N/A | N/A | |
 Central Plains Bancshares, Inc. Common Stock NASDAQ:CPBI | 508.70M | 3.2% | 4.2% | N/A | |
 UY Scuti Acquisition Corp. NASDAQ:UYSC | 239.32K | N/A | N/A | N/A |
Aimei Health Technology Co., Ltd Fair Value Envelope
Related Guides
Continue your AFJK research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.